PCRX logo

Pacira BioSciences (PCRX) EBITDA

Annual EBITDA

$154.59 M
+$14.21 M+10.12%

December 31, 2023

Summary

Performance

1-Year Change

+10.12%

3-Year Change

+143.39%

5-Year Change

+367.66%

15-Year Change

+1391.22%

PCRX EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

88.45%
PCRX annual EBITDA is higher than 88.45% of companies in Healthcare sector

High & Low

All-time High

$154.59 M
PCRX annual EBITDA is currently at an all-time high

3-Year Low

$113.95 M
PCRX annual EBITDA is currently +35.66% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
PCRX previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Feb 28, 2025
PCRX next annual earnings announcement is scheduled for Feb 28, 2025

OtherPCRXprofitabilitymetrics:

Annual Revenue

$674.98 M
PCRX annual revenue is $674.98 million

Annual Net Income

$41.95 M
PCRX annual net profit is $41.95 million

Annual EBIT

$79.01 M
PCRX annual earnings before interest & taxes is $79.01 million

Annual EPS

$0.89
PCRX annual earnings per share is $0.89

Quarterly EBITDA

-$114.75 M
-$173.32 M-295.93%

September 30, 2024

Summary

Performance

3-Month Change

-295.93%

1-Year Change

-403.46%

3-Year Change

-415.31%

5-Year Change

-415.31%

PCRX Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

2.01%
PCRX quarterly EBITDA is higher than 2.01% of companies in Healthcare sector

High & Low

All-time High

$60.08 M
PCRX quarterly EBITDA is currently -291.00% below its historical high of $60.08 million

3-Year Low

-$114.75 M
PCRX quarterly EBITDA is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
PCRX previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 28, 2025
PCRX next earnings announcement is scheduled for Feb 28, 2025

OtherPCRXprofitabilitymetrics:

Quarterly Revenue

$168.57 M
PCRX quarterly revenue is $168.57 million

Quarterly Net Income

-$143.47 M
PCRX quarterly net profit is -$143.47 million

Quarterly EBIT

-$135.01 M
PCRX quarterly earnings before interest & taxes is -$135.01 million

Quarterly EPS

-$3.11
PCRX quarterly earnings per share is -$3.11

TTM EBITDA

$33.42 M
-$152.57 M-82.03%

September 30, 2024

Summary

Performance

3-Month Change

-82.03%

1-Year Change

-72.52%

3-Year Change

-73.57%

5-Year Change

-73.57%

PCRX TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

82.89%
PCRX TTM EBITDA is higher than 82.89% of companies in Healthcare sector

High & Low

All-time High

$187.51 M
PCRX TTM EBITDA is currently -82.17% below its historical high of $187.51 million

3-Year Low

$33.42 M
PCRX TTM EBITDA is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
PCRX previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 28, 2025
PCRX next earnings announcement is scheduled for Feb 28, 2025

OtherPCRXprofitabilitymetrics:

TTM Revenue

$694.96 M
PCRX TTM revenue is $694.96 million

TTM Net Income

-$90.73 M
PCRX TTM net profit is -$90.73 million

TTM EBIT

-$42.60 M
PCRX TTM earnings before interest & taxes is -$42.60 million

TTM EPS

-$2.01
PCRX TTM earnings per share is -$2.01

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Annual EBITDA

$154.59 M
PCRX annual EBITDA is $154.59 million

Annual Net Income

$41.95 M
PCRX annual net profit is $41.95 million

Annual Interest Expense

$17.31 M
PCRX annual interest expense is $17.31 million

Annual Income Tax

$19.75 M
PCRX annual income tax is $19.75 million

Annual D&A

$75.57 M
PCRX annual depreciation & amortization is $75.57 million

PCRX EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+10.1%-403.5%-72.5%
3 y3 years+143.4%-415.3%-73.6%
5 y5 years+367.7%-415.3%-73.6%

PCRX EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+35.7%-291.0%at low-82.2%at low
5 y5-yearat high+402.7%-291.0%at low-82.2%+8.7%
alltimeall timeat high+397.6%-291.0%at low-82.2%+155.8%

Pacira BioSciences EBITDA History

DateAnnualQuarterlyTTM
Sep 2024
-
-$114.75 M(-295.9%)
$33.42 M(-82.0%)
Jun 2024
-
$58.57 M(+68.8%)
$185.99 M(-0.8%)
Mar 2024
-
$34.70 M(-36.8%)
$187.51 M(+21.3%)
Dec 2023
$154.59 M(+10.1%)
$54.91 M(+45.2%)
$154.59 M(+27.1%)
Sep 2023
-
$37.81 M(-37.1%)
$121.61 M(+5.7%)
Jun 2023
-
$60.08 M(+3275.4%)
$115.02 M(+8.7%)
Mar 2023
-
$1.78 M(-91.9%)
$105.77 M(-24.7%)
Dec 2022
$140.38 M(+23.2%)
$21.93 M(-29.7%)
$140.38 M(+4.0%)
Sep 2022
-
$31.22 M(-38.6%)
$134.96 M(-3.9%)
Jun 2022
-
$50.83 M(+39.7%)
$140.37 M(+11.0%)
Mar 2022
-
$36.39 M(+120.3%)
$126.45 M(+11.0%)
Dec 2021
$113.95 M(+79.4%)
$16.52 M(-54.9%)
$113.95 M(-6.3%)
Sep 2021
-
$36.63 M(-0.8%)
$121.61 M(+18.4%)
Jun 2021
-
$36.91 M(+54.5%)
$102.67 M(+50.0%)
Mar 2021
-
$23.89 M(-1.2%)
$68.45 M(+7.8%)
Dec 2020
$63.51 M(+106.5%)
$24.17 M(+36.6%)
$63.51 M(+36.7%)
Sep 2020
-
$17.69 M(+557.6%)
$46.45 M(+36.4%)
Jun 2020
-
$2.69 M(-85.8%)
$34.06 M(-21.2%)
Mar 2020
-
$18.96 M(+166.6%)
$43.23 M(+40.6%)
Dec 2019
$30.75 M(-7.0%)
$7.11 M(+34.2%)
$30.75 M(-25.6%)
Sep 2019
-
$5.30 M(-55.3%)
$41.35 M(-6.2%)
Jun 2019
-
$11.86 M(+83.2%)
$44.08 M(+3.3%)
Mar 2019
-
$6.48 M(-63.4%)
$42.66 M(+29.1%)
Dec 2018
$33.05 M(-376.1%)
$17.71 M(+120.5%)
$33.06 M(+16.6%)
Sep 2018
-
$8.03 M(-23.0%)
$28.34 M(+35.9%)
Jun 2018
-
$10.44 M(-433.7%)
$20.85 M(-2861.6%)
Mar 2018
-
-$3.13 M(-124.1%)
-$755.00 K(-93.7%)
Dec 2017
-$11.97 M(-35.2%)
$13.00 M(+2293.6%)
-$11.97 M(-50.1%)
Sep 2017
-
$543.00 K(-104.9%)
-$24.00 M(-42.8%)
Jun 2017
-
-$11.17 M(-22.1%)
-$41.94 M(+23.8%)
Mar 2017
-
-$14.34 M(-1575.7%)
-$33.88 M(+83.4%)
DateAnnualQuarterlyTTM
Dec 2016
-$18.48 M(-189.2%)
$972.00 K(-105.6%)
-$18.48 M(+7.4%)
Sep 2016
-
-$17.40 M(+460.6%)
-$17.21 M(-311.2%)
Jun 2016
-
-$3.10 M(-393.4%)
$8.14 M(-48.7%)
Mar 2016
-
$1.06 M(-52.8%)
$15.87 M(-23.4%)
Dec 2015
$20.70 M(+398.9%)
$2.24 M(-71.8%)
$20.70 M(-28.7%)
Sep 2015
-
$7.95 M(+72.2%)
$29.05 M(+29.9%)
Jun 2015
-
$4.62 M(-21.7%)
$22.37 M(+31.8%)
Mar 2015
-
$5.90 M(-44.3%)
$16.97 M(+294.1%)
Dec 2014
$4.15 M(-108.0%)
$10.58 M(+733.3%)
$4.31 M(-128.3%)
Sep 2014
-
$1.27 M(-262.8%)
-$15.20 M(-45.8%)
Jun 2014
-
-$780.00 K(-88.5%)
-$28.03 M(-26.4%)
Mar 2014
-
-$6.77 M(-24.1%)
-$38.08 M(-26.7%)
Dec 2013
-$51.94 M(+15.9%)
-$8.92 M(-22.8%)
-$51.94 M(-9.8%)
Sep 2013
-
-$11.56 M(+6.7%)
-$57.58 M(-3.9%)
Jun 2013
-
-$10.83 M(-47.5%)
-$59.89 M(+8.0%)
Mar 2013
-
-$20.63 M(+41.7%)
-$55.46 M(+23.7%)
Dec 2012
-$44.83 M(+30.9%)
-$14.56 M(+4.9%)
-$44.83 M(+3.9%)
Sep 2012
-
-$13.87 M(+116.9%)
-$43.15 M(+16.7%)
Jun 2012
-
-$6.40 M(-36.0%)
-$36.98 M(-1.8%)
Mar 2012
-
-$10.00 M(-22.4%)
-$37.66 M(+11.4%)
Dec 2011
-$34.23 M(+79.1%)
-$12.88 M(+67.2%)
-$33.79 M(+32.2%)
Sep 2011
-
-$7.70 M(+8.9%)
-$25.57 M(+8.0%)
Jun 2011
-
-$7.08 M(+15.4%)
-$23.67 M(+11.7%)
Mar 2011
-
-$6.13 M(+31.7%)
-$21.19 M(+13.6%)
Dec 2010
-$19.12 M(-20.7%)
-$4.66 M(-19.7%)
-$18.66 M(-9.0%)
Sep 2010
-
-$5.80 M(+26.3%)
-$20.50 M(+3.2%)
Jun 2010
-
-$4.59 M(+27.5%)
-$19.86 M(+30.1%)
Mar 2010
-
-$3.60 M(-44.6%)
-$15.26 M(+30.9%)
Dec 2009
-$24.12 M(-41.9%)
-$6.50 M(+26.1%)
-$11.66 M(+126.1%)
Sep 2009
-
-$5.16 M
-$5.16 M
Dec 2008
-$41.53 M
-
-

FAQ

  • What is Pacira BioSciences annual EBITDA?
  • What is the all time high annual EBITDA for Pacira BioSciences?
  • What is Pacira BioSciences annual EBITDA year-on-year change?
  • What is Pacira BioSciences quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Pacira BioSciences?
  • What is Pacira BioSciences quarterly EBITDA year-on-year change?
  • What is Pacira BioSciences TTM EBITDA?
  • What is the all time high TTM EBITDA for Pacira BioSciences?
  • What is Pacira BioSciences TTM EBITDA year-on-year change?

What is Pacira BioSciences annual EBITDA?

The current annual EBITDA of PCRX is $154.59 M

What is the all time high annual EBITDA for Pacira BioSciences?

Pacira BioSciences all-time high annual EBITDA is $154.59 M

What is Pacira BioSciences annual EBITDA year-on-year change?

Over the past year, PCRX annual EBITDA has changed by +$14.21 M (+10.12%)

What is Pacira BioSciences quarterly EBITDA?

The current quarterly EBITDA of PCRX is -$114.75 M

What is the all time high quarterly EBITDA for Pacira BioSciences?

Pacira BioSciences all-time high quarterly EBITDA is $60.08 M

What is Pacira BioSciences quarterly EBITDA year-on-year change?

Over the past year, PCRX quarterly EBITDA has changed by -$152.57 M (-403.46%)

What is Pacira BioSciences TTM EBITDA?

The current TTM EBITDA of PCRX is $33.42 M

What is the all time high TTM EBITDA for Pacira BioSciences?

Pacira BioSciences all-time high TTM EBITDA is $187.51 M

What is Pacira BioSciences TTM EBITDA year-on-year change?

Over the past year, PCRX TTM EBITDA has changed by -$88.19 M (-72.52%)